Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upper respiratory tract infections in family practice

G Ruoff1

  • 1Department of Clinical Research, West Side Family Medical Center, Kalamazoo, MI 49009, USA.

The Pediatric Infectious Disease Journal
|September 4, 1998
PubMed
Summary

Common respiratory pathogens like Streptococcus pneumoniae are increasingly resistant to antibiotics. Alternative therapies are being explored for upper respiratory tract infections, considering factors like pediatric compliance and efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.

Current medical research and opinion·2006
Same author

Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease.

Alimentary pharmacology & therapeutics·2004
Same author

Using a flow sheet to improve performance in treatment of elderly patients with type 2 diabetes.

Family medicine·1999
Same author

A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.

Pharmacotherapy·1998
Same author

Management of pain in patients with multiple health problems: a guide for the practicing physician.

The American journal of medicine·1998
Same author

Over-the-counter analgesics and kidney disease.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1996

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Common upper respiratory tract infections (URTIs) are frequently caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • Empirical treatment is standard, but rising antimicrobial resistance, particularly with S. pneumoniae, necessitates reevaluation of therapeutic strategies.
  • Amoxicillin remains a first-line option, but alternative treatments are crucial in specific clinical scenarios.

Purpose of the Study:

  • To review current therapeutic approaches for bacterial URTIs.
  • To highlight the need for alternative antimicrobial therapies due to increasing resistance.
  • To emphasize considerations for effective treatment, including pathogen coverage and patient compliance.

Main Methods:

Related Experiment Videos

  • Literature review of clinical trials and expert recommendations.
  • Analysis of antimicrobial resistance patterns for common respiratory pathogens.
  • Evaluation of factors influencing treatment success, such as administration ease and adverse events.

    • Main Results:

    • Increasing antimicrobial resistance necessitates exploring alternative therapies beyond amoxicillin.
    • Effective treatment requires balancing pathogen coverage with patient compliance, especially in pediatrics.
    • Clinical evidence supports the use of alternative antimicrobial agents for URTIs.

    Conclusions:

    • Alternative antimicrobial therapies are essential for managing bacterial URTIs, particularly those caused by resistant pathogens.
    • Treatment strategies must consider pathogen susceptibility, clinical efficacy, and patient-specific factors like compliance.
    • Further research and clinical evaluation of alternative treatments are warranted to optimize URTI management.